|
72
|
240
|
4qv6C |
Ycp beta5-a49v mutant |
|
56
|
234
|
4r3oE |
Human constitutive 20s proteasome |
|
59
|
222
|
4qz7H |
Ycp beta5-a50v mutant in complex with the epoxyketone inhibitor onx 0914 |
|
70
|
240
|
4qlvC |
Ycp in complex with tripeptidic epoxyketone inhibitor 17 |
|
64
|
241
|
4qwxG |
Ycp in complex with the epoxyketone inhibitor onx 0914 |
|
66
|
212
|
4qvnK |
Ycp beta5-m45v mutant in complex with bortezomib |
|
68
|
212
|
4qv0K |
Ycp beta5-a49t-a50v-double mutant |
|
68
|
250
|
4qz5A |
Ycp beta5-a49t-mutant in complex with onx 0914 |
|
68
|
242
|
4qwrD |
Ycp beta5-c52f mutant in complex with carfilzomib |
|
71
|
240
|
4qw0C |
Ycp beta5-a49t-a50v-double mutant in complex with bortezomib |
|
69
|
233
|
4qvpM |
Ycp beta5-m45t mutant in complex with bortezomib |
|
62
|
241
|
4qwrG |
Ycp beta5-c52f mutant in complex with carfilzomib |
|
69
|
240
|
4qw3C |
Ycp beta5-c63f mutant in complex with bortezomib |
|
71
|
232
|
4qz7M |
Ycp beta5-a50v mutant in complex with the epoxyketone inhibitor onx 0914 |
|
59
|
222
|
4qv6L |
Ycp beta5-a49v mutant |
|
61
|
222
|
4qlvH |
Ycp in complex with tripeptidic epoxyketone inhibitor 17 |
|
69
|
233
|
4qwiM |
Ycp beta5-a49s-mutant in complex with carfilzomib |
|
63
|
201
|
4r673 |
Human constitutive 20s proteasome in complex with carfilzomib |
|
66
|
242
|
4qz3D |
Ycp beta5-a49v mutant in complex with the epoxyketone inhibitor onx 0914 |
|
70
|
240
|
4qv5C |
Ycp beta5-m45i mutant |
|
57
|
222
|
4qzwH |
Ycp beta5-c52f mutant in complex with the epoxyketone inhibitor onx 0914 |
|
57
|
204
|
4qwrI |
Ycp beta5-c52f mutant in complex with carfilzomib |
|
66
|
233
|
4qw7M |
Ycp beta5-m45t mutant in complex with carfilzomib |
|
66
|
244
|
4qluB |
Ycp in complex with tripeptidic epoxyketone inhibitor 9 |
|
68
|
244
|
4qzxB |
Ycp beta5-c63f mutant in complex with the epoxyketone inhibitor onx 0914 |
|
73
|
212
|
4qz1K |
Ycp beta5-m45t mutant in complex with the epoxyketone inhibitor onx 0914 |
|
68
|
230
|
4qwjM |
Ycp beta5-a49t-mutant in complex with carfilzomib |
|
68
|
233
|
4r02M |
Ycp in complex with bsc4999 (alpha-keto phenylamide) |
|
70
|
240
|
4qvnC |
Ycp beta5-m45v mutant in complex with bortezomib |
|
64
|
231
|
4qwfE |
Ycp beta5-m45i mutant in complex with carfilzomib |
|
59
|
196
|
4qvmN |
Ycp beta5-m45a mutant in complex with bortezomib |
|
58
|
222
|
4qw7H |
Ycp beta5-m45t mutant in complex with carfilzomib |
|
65
|
231
|
4qv6E |
Ycp beta5-a49v mutant |
|
60
|
196
|
4qlsN |
Ycp in complex with tripeptidic epoxyketone inhibitor 11 |
|
66
|
244
|
4qzwB |
Ycp beta5-c52f mutant in complex with the epoxyketone inhibitor onx 0914 |
|
60
|
222
|
4qwxL |
Ycp in complex with the epoxyketone inhibitor onx 0914 |
|
69
|
243
|
4qlsF |
Ycp in complex with tripeptidic epoxyketone inhibitor 11 |
|
66
|
231
|
4qw7E |
Ycp beta5-m45t mutant in complex with carfilzomib |
|
72
|
244
|
4quxB |
Ycp beta5-a49t-mutant |
|
69
|
233
|
4qzzM |
Ycp in complex with omuralide |
|
68
|
244
|
4qz4B |
Ycp beta5-a49s mutant in complex with the epoxyketone inhibitor onx 0914 |
|
59
|
226
|
4qvnH |
Ycp beta5-m45v mutant in complex with bortezomib |
|
70
|
243
|
4qv4F |
Ycp beta5-m45t mutant |
|
57
|
233
|
4r67B |
Human constitutive 20s proteasome in complex with carfilzomib |
|
61
|
195
|
4qz2J |
Ycp beta5-m45i mutant in complex with the epoxyketone inhibitor onx 0914 |
|
62
|
231
|
4qwkE |
Ycp beta5-a49t-a50v-double mutant in complex with carfilzomib |
|
73
|
240
|
4qvvC |
Ycp beta5-a49v mutant in complex with bortezomib |
|
63
|
231
|
4qv3E |
Ycp beta5-m45v mutant |
|
66
|
212
|
4qwuK |
Ycp beta5-c52f mutant in complex with bortezomib |
|
66
|
242
|
4qw5D |
Ycp beta5-m45a mutant in complex with carfilzomib |
